Tagged With "FDA"

Blog Post

AAFA Brings Perspective of Asthma, Allergy Patients to FDA

AAFA Community Services ·
What is it like to have food allergies, asthma, or nasal allergies? What do patients need and want from their treatments? How can we improve allergy care? The chief executive officer of the Asthma and Allergy Foundation of America spoke about these issues at a recent FDA advisory committee meeting. Dr. Cary Sennett spoke to the Allergenic Products Committee about the everyday challenges of life with food allergies, asthma and other allergies. Dr. Sennett attended the meeting to represent...
Blog Post

FDA Approves Cinqair to Treat Severe Asthma

AAFA Community Services ·
FDA News Release FDA approves Cinqair to treat severe asthma For Immediate Release March 23, 2016 Inquiries Media Andrea Fischer 301-796-0393 Consumers 888-INFO-FDA Release The U.S. Food and Drug Administration today approved Cinqair (reslizumab) for use with other asthma medicines for the maintenance treatment of severe asthma in patients aged 18 years and older. Cinqair is approved for patients who have a history of severe asthma attacks (exacerbations) despite receiving their current...
Blog Post

FDA Approves First Seasonal Influenza Vaccine Containing an Adjuvant

AAFA Community Services ·
The U.S. Food and Drug Administration approved Fluad, the first seasonal influenza vaccine containing an adjuvant.
Blog Post

FDA Proposes Ban on Most Powdered Medical Gloves

AAFA Community Services ·
FDA News Release FDA proposes ban on most powdered medical gloves For Immediate Release March 21, 2016 Release Today, the U.S. Food and Drug Administration announced a proposal to ban most powdered gloves in the United States. While use of these gloves is decreasing, they pose an unreasonable and substantial risk of illness or injury to health care providers, patients and other individuals who are exposed to them, which cannot be corrected through new or updated labeling. The proposed ban...
×
×
×
×